Ultragenyx Pharmaceutical

RARENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.554 B

$25.91 +0.35%

Close of 7 Aug 2026

Revenue

$673.0M

#1759 by revenue

Earnings

-$575.0M

Loss-making

Shares outstanding

98,588,873

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#90PrecigenPGEN$2.59B
#91Nektar TherapeuticsNKTR$2.58B
#92Ultragenyx PharmaceuticalRARE$2.55B
#93Amylyx PharmaceuticalsAMLX$2.54B
#94PharvarisPHVS$2.43B

Where these numbers come from

Share counts and financials for Ultragenyx Pharmaceutical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.